A phase Ib trial of alpelisib and weekly cisplatin in patients with solid tumor malignancies.
2021
3134Background: The PI3K pathway may represent a mechanism to overcome cisplatin resistance, particularly in human papilloma virus (HPV)-associated tumors. We conducted a phase Ib trial of alpelisi...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI